Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.2150 (0.32%) ($14.2150 - $14.2150) on Thu. Oct. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.13% (three month average) | RSI | 59 | Latest Price | $14.2150(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(31%) URA(30%) VT(30%) VUG(30%) BLOK(29%) | Factors Impacting BCRX price | BCRX will decline at least -2.065% in a week (0% probabilities). SMH(-13%) VIXM(-12%) UUP(-11%) VXX(-2%) EDOC(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.065% (StdDev 4.13%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.58(4.68%) | 10 Day Moving Average | $13.06(8.84%) | 20 Day Moving Average | $13.13(8.26%) | To recent high | -4.1% | To recent low | 31.9% | Market Cap | $2.508b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |